Long-term outcome of Peripartum cardiomyopathy in a population with high seropositivity for Human Immunodeficiency Virus

International Journal of Cardiology

Volumn 147, Issue 2, 2011, Pages 202-208

  Sliwa, Karen ^a   Forster, Olaf ^a   Tibazarwa, Kemi ^a   Libhaber, Elena ^a   Becker, Anthony ^a   Yip, Anthony ^a   Hilfiker Kleiner, Denise ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Africa; Long term outcome; Mortality; Peripartum cardiomyopathy

Indexed keywords

C REACTIVE PROTEIN; FAS ANTIGEN; HEMOGLOBIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AFRICA; ARTICLE; CARDIOMYOPATHY; CLINICAL ASSESSMENT; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MORTALITY; OUTCOME ASSESSMENT; PERIPARTUM CARDIOMYOPATHY; POPULATION RESEARCH; PREGNANCY; PRIMIGRAVIDA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUERPERIUM; SURVIVAL RATE; TERTIARY HEALTH CARE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; CARDIOMYOPATHY, DILATED; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HIV SEROPOSITIVITY; HUMANS; PERIPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; SOUTH AFRICA; TIME FACTORS; YOUNG ADULT;

EID: 79951956985     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.08.022     Document Type: Article

References (34)

1. Pearson GD, Veille JC, Rahimtoola S, et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. Jama 2000;283(9):1183-8.
2. Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet 2006;368(9536):687-93. (Pubitemid 44223695)
3. Elkayam U, Akhter MW, Singh H, et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 2005;111(16):2050-5. (Pubitemid 40577899)
4. Brar SS, Khan SS, Sandhu GK, et al. Incidence, mortality, and racial differences in peripartum cardiomyopathy. Am J Cardiol 2007;100(2):302-4. (Pubitemid 47041992)
5. Fett JD, Christie LG, Carraway RD, Murphy JG. Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc Dec 2005;80(12):1602-6. (Pubitemid 41747062)
6. Lamparter S, Pankuweit S, Maisch B. Clinical and immunologic characteristics in peripartum cardiomyopathy. Int J Cardiol May 16 2007;118(1):14-20. Electronic publication 2006 Aug 10.
7. Sliwa K, Skudicky D, Candy G, Bergemann A, Hopley M, Sareli P. The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy. Eur J Heart Fail 2002;4(3):305-9. (Pubitemid 35190355)
8. Sliwa K, Forster O, Libhaber E, et al. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J 2006;27(4):441-6. (Pubitemid 43209169)
9. Hilfiker-Kleiner D, Kaminski K, Podewski E, et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 2007;128(3):589-600. (Pubitemid 46206082)
10. Tabruyn SP, Sabatel C, Nguyen NQ, et al. The angiostatic 16 K human prolactin overcomes endothelial cell anergy and promotes leukocyte infiltration via nuclear factor-kappaB activation. Mol Endocrinol 2007;21(6):1422-9. (Pubitemid 46984747)
11. Forster O, Hilfiker-Kleiner D, Ansari AA. Reversal of IFN-gamma, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy. Eur J Heart Fail Sep 2008;10(9):861-8. Electronic publication 2008 Sep 2.
12. Dorrington R, Bourne D. Re-estimate provincial HIV anrenatal survey prevalence for 2007 and a reinterpretation of the national trend. SAMJ 2008;98:940-1.
13. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58(6):1072-83. (Pubitemid 9091990)
14. Sliwa K, Skudicky D, Bergemann A, Candy G, Puren A, Sareli P. Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. J Am Coll Cardiol 2000 Mar 1;35(3):701-5. (Pubitemid 30167027)
15. National Department of Health of South Africa; 2004. http://www.doh.gov. za.docs/factsheets/guidelines/artguidelines04. accessed 12 August 2009.
16. Murali S, Baldisseri MR. Peripartum cardiomyopathy. Crit Care Med. 2005 Oct;33 (10 Suppl):S340-S346. (Pubitemid 41437459)
17. Ntusi NB, Mayosi BM. Aetiology and risk factor in peripartum Cardiomyopathy: a systematic review. Int J Cardiol 2009;131:168-79.
18. Amos AM, Jaber WA, Russell SD. Improved outcomes in peripartum cardiomyopathy with contemporary. Am Heart J 2006 Sep;152(3):509-13. (Pubitemid 44233417)
19. Gouley BA, McMillan TM, Bellet S. Idiopathic myocardial degeneration associated with pregnancy and especially the puerperium. Am J Med Sci 1937;194:185-99.
20. Bultmann BD, Klingel K, Nabauer M, Wallwiener D, Kandolf R. High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am J Obstet Gynecol 2005;193:363-5. (Pubitemid 41159528)
21. Cenac A, Djibo A, Djangnikpo L. Peripartum dilated cardiomyopathy. A model of multifactor disease? Rev Med Interne 1993;14(1033).
22. Cenac A, Gaultier Y, Devillechabrolle A, Moulias R. Enterovirus infection in peripartum cardiomyopathy. Lancet 1988;2:968-9.
23. Fett JD. Viral infection as a possible trigger for the development of peripartum cardiomyopathy. Int J Gynaecol Obstet 2007;97:149-50. (Pubitemid 46613797)
24. Midei MG, DeMent SH, Feldman AM, Hutchins GM, Baughman KL. Peripartum myocarditis and cardiomyopathy. Circulation 1990;81:922-8. (Pubitemid 20090390)
25. Felker GM, Jaeger CJ, Klodas E, et al. Myocarditis and long-term survival in peripartum cardiomyopathy. Am Heart J 2000;140:785-91.
26. Rizeq MN, Rickenbacher PR, Fowler MB, Billingham ME. Incidence of myocarditis in peripartum cardiomyopathy. Am J Cardiol 1994;74:474-7. (Pubitemid 24269967)
27. Nag VL, Agarwal P, Venkatesh V, et al. A pilot study on observations on CD4 & CD8 counts in healthyHIVseronegative individuals. Indian JMed Res Aug 2002;116:45-9. (Pubitemid 36131236)
28. Gomo E, Vennervald BJ, Ndhlovu PD, et al. Reference values and predictors of white blood cell subset counts: a cross-sectional study among HIV seronegative pregnant women in Zimbabwe. Eur J Obstet Gynecol Reprod Biol Apr 25 2003;107(2):156-62. (Pubitemid 36332053)
29. Gomo E, Vennervald BJ, Ndhlovu P, et al. Predictors and reference values of CD4 and CD8 T lymphocyte counts in pregnancy: a cross sectional study among HIV negative women in Zimbabwe. Cent Afr J Med Jan-Feb 2004;50(1-2):10-9.
30. Taffé P, May M. Swiss HIV Cohort Study. A joint back calculation model for the imputation of the date of HIV infection in a prevalent cohort. Stat Med Oct 15 2008;27(23):4835-53.
31. Jacob AJ, Sutherland GR, Bird AG, et al. Myocardial dysfunction in children infected with immunodeficiency virus: the prospective P2C2 HIV Multicentre Study. Circulation 1998;97:1246-56.
32. Rerkpattanapipat P, Wongprapurat N, Jacobs LE, Kotler MN. Cardiac manifestations of acquired immunodeficiency syndrome. Arch Intern Med 2000;160:601-8.
33. Levin A. Anemia and left ventricular hypertrophy in chronic kidney disease populations: a review of the current state of knowledge. Kidney Int Suppl May 2002(80):35-8.
34. Coats AJ. Ethical authorship and publishing. Int J Cardiol 2009;131:149-50.